Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to evaluate the utility and efficacy of an artificial intelligence (AI) model at identifying structures and phases of surgery compared to traditional white light assessment by trained surgeons. Surgeons will perform the procedure in their standard practice, while the AI model analyzes data from the laparoscopic camera. Surgeons will be asked to audibly state when they identify structures and enter different phases of the surgical procedure. The AI will not alter the surgeon's view or be visible to the surgeon, and the surgeon will perform the procedure in the exact same fashion as they typically do.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• All patients age \> 18 years old who are planned for elective laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.

• Eligible patients will be screened and assigned as per risk calculator for difficulty of LC

• Diagnosis:

‣ All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.

⁃ Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.

• Prior therapy:

• o Patients with prior surgery are eligible for enrollment.

• Laboratory:

‣ Hemoglobin \> 9 g/dL

⁃ Platelet count ≥75,000/µL (may receive transfusions)

⁃ Normal prothrombin time (PT), partial thromboplastin time (PTT) and international normalized ratio (INR) \< 1.5 x upper limit of normal (including patients on prophylactic anticoagulation)

⁃ Liver Function Test

⁃ Renal function: Age-adjusted normal serum creatinine

⁃ Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry \>94% on room air if there is any clinical indication for determination.

Locations
United States
Texas
Memorial Hermann Texas Medical Center
RECRUITING
Houston
Contact Information
Primary
Christopher McCulloh, MD
cmcculloh@activsurgical.com
617-333-8162
Time Frame
Start Date: 2023-08-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 120
Treatments
Experimental: Indocyanine green (ICG)
Patients in this arm will receive an intravenous injection of indocyanine green (ICG) 45 minutes prior to the start of surgery. This will be used to visualize the biliary anatomy using ActivSight, a device that is FDA 510(k)-cleared for this indication.~The surgeon will perform the procedure in their standard fashion using ActivSight.~ActivInsight artificial intelligence will be used to analyze the surgical video in real time to identify anatomic structures and phases of surgery.
No_intervention: Non-Indocyanine Green (Non-ICG)
The surgeon will perform the procedure in their standard fashion without the use of ICG.~ActivInsight artificial intelligence will be used to analyze the surgical video in real time to identify anatomic structures and phases of surgery.
Sponsors
Leads: Activ Surgical

This content was sourced from clinicaltrials.gov